|
|
|
|
Vol. 12, Issue 11, 3631-3643, November 2001


§
¶
*Eukaryotic Genetics Group, Biotechnology Research Institute,
National Research Council of Canada, Montreal, Quebec H4P 2R2, Canada;
the
Institute of Clinical Microbiology, Immunology, and
Hygiene, University of Erlangen, D-91054 Erlangen, Germany; and the
Departments of
Anatomy and Cell Biology,
§Biology, and
Experimental Medicine, McGill
University, Montreal, Canada
| |
ABSTRACT |
|---|
|
|
|---|
The human fungal pathogen Candida albicans switches
from a budding yeast form to a polarized hyphal form in response to
various external signals. This morphogenetic switching has been
implicated in the development of pathogenicity. We have cloned the
CaCDC35 gene encoding C. albicans
adenylyl cyclase by functional complementation of the conditional
growth defect of Saccharomyces cerevisiae cells with
mutations in Ras1p and Ras2p. It has previously been shown that these
Ras homologues regulate adenylyl cyclase in yeast. The C.
albicans adenylyl cyclase is highly homologous to other fungal
adenylyl cyclases but has less sequence similarity with the mammalian
enzymes. C. albicans cells deleted for both alleles of
CaCDC35 had no detectable cAMP levels, suggesting that
this gene encodes the only adenylyl cyclase in C.
albicans. The homozygous mutant cells were viable but grew more
slowly than wild-type cells and were unable to switch from the yeast to
the hyphal form under all environmental conditions that we analyzed in
vitro. Moreover, this morphogenetic switch was completely blocked in
mutant cells undergoing phagocytosis by macrophages. However,
morphogenetic switching was restored by exogenous cAMP. On the basis of
epistasis experiments, we propose that CaCdc35p acts downstream of the
Ras homologue CaRas1p. These epistasis experiments also suggest that the putative transcription factor Efg1p and components of the hyphal-inducing MAP kinase pathway depend on the function of CaCdc35p in their ability to induce morphogenetic switching. Homozygous cacdc35
cells were unable to establish vaginal
infection in a mucosal membrane mouse model and were avirulent in a
mouse model for systemic infections. These findings suggest that fungal
adenylyl cyclases and other regulators of the cAMP signaling pathway
may be useful targets for antifungal drugs.
| |
INTRODUCTION |
|---|
|
|
|---|
Candida albicans is a major fungal
pathogen of humans, and infections with this fungus are a particular
problem in immune compromised patients. C. albicans grows in
several morphological forms. Under conditions of moderate temperature
and low pH and in the absence of inducers such as serum or
N-acetylglucosamine, the cells grow as budding yeasts
(Castilla et al., 1998
). Increases in temperature to 37°C,
increases in pH, and the addition of inducers can stimulate the
formation of filamentous forms. These filamentous forms include
pseudohyphae (chains of elongated cells) as well as true hyphae, where
growth involves parallel-sided walls with the cells separated by septa
(Mitchell, 1998
). The finding that mutant strains defective in hyphal
growth are avirulent (Leberer et al., 1997
; Lo et
al., 1997
) has implicated the yeast-hyphal transition in C. albicans pathogenicity.
Adenosine 3':5'-cyclic monophosphate (cAMP) plays a role in the
differentiation of many fungi, and dimorphic behavior has often been
linked to intracellular levels of this cyclic nucleotide. In
Schizosaccharomyces pombe, deletion of the adenylyl cyclase gene does not affect viability but derepresses conjugation and sporulation under conditions that normally inhibit these
differentiation stages in wild-type cells (Kawamukai et al.,
1991
). In contrast, adenylyl cyclase mutants of Magnaporthe
grisea have decreased vegetative growth rate, are sterile, and are
defective in forming appresoria on an inductive surface and thus are
unable to infect susceptible rice leaves (Choi and Dean, 1997
). In
Cryptococcus neoformans, the cAMP signaling pathway
functions to sense nutritional signals that regulate mating and the
induction of virulence factors such as melanin and capsules (Alspaugh
et al., 1997
). In Ustilago maydis, mutations in
the gene encoding adenylyl cyclase cause constitutive growth (Gold
et al., 1994
), whereas strains with defects in the gene
encoding the regulatory subunit of protein kinase A (PKA) are incapable
of forming tumors in plants (Gold et al., 1997
; Durrenberger
et al., 1998
). In addition, in Neurospora crassa
the regulatory subunit of PKA has been demonstrated to play a role in
polarized growth and the localization of septa (Bruno et
al., 1996
), whereas adenylyl cyclase has been shown to control
carbon source utilization (Terenzi et al., 1979
). Recently, regulation of adenylyl cyclase protein levels in N. crassa
has been shown to be controlled by a G protein
subunit (Kays
et al., 2000
).
In the yeast Saccharomyces cerevisiae, cAMP signaling has
been found to be essential for growth, and together with a mitogen activated protein (MAP) kinase signaling pathway, has been found to
play a role in pseudohyphal differentiation (Kronstad et
al., 1998
; Thevelein and de Winde, 1999
; Borges-Walmsley and
Walmsley, 2000
). Deletion of the CDC35/CYR1 gene
encoding adenylyl cyclase causes yeast cells to arrest in G1 of the
cell cycle (Matsumoto et al., 1982
; Kataoka et
al., 1985
). The activity of adenylyl cyclase is regulated by the
yeast Ras homologues Ras1p and Ras2p (DeFeo-Jones et al.,
1985
; Toda et al., 1985
; Field et al., 1988
). Simultaneous depletion of these homologues is lethal (Kataoka et
al., 1984
, 1985
; Tatchell et al., 1985
). Moreover, in
addition to the Ras proteins, the G protein
subunit homologue Gpa2p
appears also to modulate the activity of adenylyl cyclase (Kubler
et al., 1997
; Lorenz and Heitman, 1997
; Colombo et
al., 1998
). Mutant cells defective in either RAS2 or
GPA2 have normal vegetative growth, but double mutant cells
exhibit very slow growth even on rich medium. This defect can be
suppressed by exogenous cAMP or by mutation in the PDE2 gene
encoding cAMP phosphodiesterase (Kubler et al., 1997
; Xue
et al., 1998
). Ras2p and Gpa2p are both required for
filamentous growth in S. cerevisiae, and evidence suggests
that Ras2p might be the activator of both the cAMP and the MAP kinase
pathways that control filamentous growth (Kronstad et al.,
1998
; Thevelein and de Winde, 1999
; Borges-Walmsley and Walmsley,
2000
).
In C. albicans, a role for cAMP in the yeast to hyphal
switch has been controversial. Some research provides evidence for a
transient rise in cAMP levels during germ tube formation (Niimi et al., 1980
; Chattaway et al., 1981
; Sabie and
Gadd, 1992
), but other studies support a transient decrease due to
increased phosphodiesterase activity (Egidy et al., 1990
) or
provide no evidence at all for fluctuations in cAMP levels during the
yeast-to-hyphal switch (Sullivan et al., 1983
). Genetic
evidence for a potential role of cAMP in dimorphic switching has come
from the cloning of the CaTPK2 gene encoding a C. albicans homologue of the catalytic subunit of PKA (Sonneborn
et al., 2000
). Deletion of both CaTPK2 alleles
interferes with morphogenesis under some environmental conditions and
partially reduces virulence in a mouse model for systemic candidiasis.
Biochemical characterization of a protein with PKA activity but a
molecular weight size that is different from the protein encoded by
CaTPK2 suggests that a second C. albicans homologue of the PKA catalytic subunit might exist (Zelada et al., 1998
). Consistent with this view is the observation that a
second gene encoding a homologue of the catalytic subunit of PKA is
present in the C. albicans genome
(http://sequence-www.stanford.edu/group/candida/index.html).
Additional support for a role of the cAMP pathway in dimorphic
switching of C. albicans has involved the phenotypic
characterization of a gene encoding a homologue of Ras. This homologue
has been shown to be required for the yeast-to-hyphal switch (Feng
et al., 1999
) and to contribute to virulence in an animal
model through regulation of the MAP kinase and cAMP signaling pathways
(Leberer et al., 2001
). In this study, we describe
the isolation and functional characterization of the CaCDC35
gene encoding a homologue of adenylyl cyclase. We provide genetic
evidence that signal transduction through adenylyl cyclase contributes
to vegetative growth of C. albicans cells and is essential
for dimorphic differentiation in response to environmental cues and for
virulence in mouse models for vaginal and systemic fungal infections.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Isolation of CaCDC35
The CaCDC35 gene was isolated in a screen searching
for C. albicans genes capable of suppressing the
temperature-sensitive growth defect of the ras1
ras2ts S. cerevisiae strain TTM3-4B
(Powers et al., 1989
) as described (Leberer et
al., 2001
). In addition to plasmids carrying
CaRAS1 (Leberer et al., 2001
), we isolated
from a genomic C. albicans library constructed in the
S. cerevisiae vector YEp352 (Boone et al., 1991
)
plasmids pDH222 and pDH223 carrying inserts of 2.3 and 5.2 kb,
respectively. Plasmid pDH222 carried an open reading frame of 1311 bp
encoding the carboxyl terminal catalytic domain of adenylyl cyclase
from amino acids 1254-1690. Plasmid pDH223 contained an open reading
frame of 4917 bp encoding a carboxyl terminally truncated version of
adenylyl cyclase from amino acids 1-1639. To create plasmid pCR0
containing the complete coding region of CaCDC35, a 5.1-kb
SphI-EcoRI fragment of plasmid pDH223 was ligated
to a 1.17-kb EcoRI fragment from pDH222 in pTZ18R (Mead
et al., 1986
). To identify more 5' upstream noncoding
sequences of CaCDC35, we screened the C. albicans
genomic library by colony hybridization under high-stringency (Feinberg
and Vogelstein, 1983
) and isolated plasmid pCR21 containing 2743 bp of
sequence upstream of the coding region and 4743 bp of sequence within
the coding region of CaCDC35.
Yeast Manipulations
The C. albicans and S. cerevisiae strains
used in this study are listed in Table 1.
Media and culture conditions for the growth of C. albicans
and S. cerevisiae cells were as described (Rose et
al., 1990
). All media were supplemented with uridine (25 µg/ml)
for the growth of C. albicans Ura- strains. Transformation of S. cerevisiae and C. albicans cells were
performed by the lithium acetate method and spheroplast methods,
respectively (Rose et al., 1990
). Plasmid DNA was isolated
from S. cerevisiae cells as described (Rose et
al., 1990
).
|
Plasmids
All plasmids used in this study are listed in Table 1. PCRs were
performed with the use of the Expand High Fidelity or Long Template PCR
system (Boehringer Mannheim, Laval, Quebec, Canada). Fragments
generated by PCR were always sequenced to ensure no unanticipated
mutations were introduced during the amplification procedure. To
construct pCR1, we amplified a 6.2-kb fragment containing the complete
open reading frame of CaCDC35 and 242 bp of upstream regulatory region with the use of the oligodeoxynucleotides
5'-CGGGATCCGATCAACACATTTTTAAT-3' and
5'-CGGGTACCTCATGTATCCTTTAGGAA-3' (the newly created
BamHI and KpnI sites, respectively, are
underlined) and pCR0 as a template. The amplified fragment was then
cloned into pVEC (Magee and Magee, 1997
). To construct pCR2, we
amplified a 5.9-kb fragment containing the complete open reading frame
of CaCDC35 with the use of the oligonucleotides
5'-CGACGCGTATGAGTTT-TTTAAGGAGA-3' and
5'-CGACGCGTTAATCCAACCAATTGA-TT-3' (the newly created
MluI sites are underlined; the start codon is in italics)
and pCR0 as template, and cloned the fragment into pYPB1-ADHpL (Leberer
et al., 1996
). To place CaCDC35 under the control
of the CaPCK1 promoter, we first constructed plasmid pCR4 by
cloning a BamHI-BglII fragment with the
CaPCK1 promoter from plasmid pCAO1 (Leuker et
al., 1997
) into pVEC. Next, we PCR-amplified the complete open
reading frame of CaCDC35 with the use of the oligodeoxynucleotides 5'-CGGGTACCATGAGTTT-TTTAAGGAGA-3' and 5'-CGGGTACCCAAATAGTATATAAAT-CG-3' (the newly created KpnI sites are underlined; the start
codon is in italics) and cloned the amplified 5.9-kb fragment into the KpnI site of pCR4.
The integration plasmid pCRQ38 contains CaCDC35, CaTRP1 for integration into the TRP1 locus, and CaURA3 as selectable marker. It was generated by cloning, into the BamHI site of pCR1, a 1.4-kb PCR fragment of the CaTRP1 gene amplified by PCR with the use of the divergent oligodeoxynucleotide primers OJA19 (5'-CG-AGATCTTAAGCCGTGCTGGCGTGAAT-3') and OJA17 (5'-CG-AGATCTCATGAGACACTGGTCTCGCGTCTG-3') (the newly introduced BglII sites are underlined) and with the use of plasmid pJA39 as template.
Plasmid pDH240 was constructed by cloning a SmaI fragment
containing the complete open reading frame of CaRAS1
(Leberer et al., 2001
) into the EcoRV site
of pYPBl-ADHpL. Plasmid pSU1 was derived from pDH233, which is
wild-type RAS cloned as a PstI-HindIII fragment in pVEC, by site-directed mutagenesis with the use of the
QuickChange Site-Directed Mutagenesis kit from Stratagene (La Jolla,
CA). The oligodeoxynucleotide primer pairs were
5'-GTTGTTGTTGGAGGAGTTGGTGTTGGTAAATCCGC-3' and
5'-GCGGATTTACCAACACCAACTCCTCCAACAACAAC-3' for replacing the glycine
residue at position 13 into a valine residue. The mutant RAS1 allele was then cut with SmaI and
transferred to EcoRV cut YPB1-ADHpL to generate pLJ57.
Plasmid pJA39 consists of the C. albicans TRP1 inserted into pVEC.
Deletion of CaCDC35
To construct a CaCDC35 deletion cassette, a DNA
fragment that contained CaCDC35 flanking sequences from
nucleotide positions
242-218 and 5649-6275, respectively, joined
with BamHI sites was created by PCR with the use of the
divergent oligodeoxynucleotide primers OCR1
(5'-CGGGATCCTTCAAATGGTGGGTAGCTGAG3') and OCR2
(5'CGGGATCCCACCTTCAGCTGAAGCAACAC-3'; newly introduced
BamHI sites are underlined) and plasmid pCR0 as template.
The amplified DNA was cleaved with BamHI and ligated with a
BamHI-BglII hisG-CaURA3-hisG cassette
from plasmid p5921 to yield plasmid pCRF3. This plasmid was linearized
with SphI and BspMII and transformed into the
Ura
C. albicans strain CAI4 (Fonzi
and Irwin, 1993
). Transformants in which the coding region of one of
the chromosomal CaCDC35 alleles was replaced by homologous
recombination with the hisG-CaURA3-hisG cassette were
selected on Ura
medium. Integration of the
cassette into the CaCDC35 locus was confirmed by Southern
blot analysis with the use of a SphI to SpeI
fragment from nucleotide positions
1366 to
630 as a probe (Figure
1, A and B). Spontaneous
Ura
derivatives were then selected on medium
containing 5-fluoro-orotic acid as described (Fonzi and Irwin, 1993
).
These clones were screened by Southern blot hybridization to identify
those that had lost the CaURA3 gene by intrachromosomal
recombination mediated by the hisG repeats. The remaining
functional allele of CaCDC35 was then deleted by repeating
the same procedure. With the use of this two-step approach, we
independently isolated the homozygous cacdc35
/cacdc35
strains CR153 and CR216 that showed the identical structural and
phenotypic behavior.
|
To reintegrate the CaCDC35 gene into the CaTRP1
locus, strain CR276
(cacdc35
::hisG/cacdc35
::hisG) was
transformed with plasmid pCRQ38 linearized with
BsiWI, and recombinants were selected on -ura
medium. Correct integration of CaCDC35 at the
CaTRP1 locus was then confirmed by Southern blot analysis.
Northern Blot Analysis
Northern blots of total RNA and poly(A)+
RNA from C. albicans were performed as described (Leberer
et al., 1992
). The probe for CaCDC35 was a 3.7-kb
NheI-SacII fragment from nucleotide positions 432-4159, and the CaACT1 probe was an
EcoRI-HindIII fragment of the CaACT1
gene (Losberger and Ernst, 1989
).
Phenotypic Characterization of cacdc35
C. albicans Mutant Cells
Proliferation of C. albicans cells was determined in YPD medium at 30°C. An overnight culture was diluted to OD600 = 0.1 into fresh medium and grown at 30°C. The density at 600 nm (OD600) of each culture was determined every hour over a period of 8 h. For the analysis of colony morphology, microphotographs of single colonies were taken directly from Petri plates by phase contrast microscopy. To analyze filaments, microphotographs were taken with a Leitz Aristoplan microscope with the use of Nomarski optics at 1000× magnification (Leitz, Wetzlar, Germany).
Measurements of cAMP levels were performed as described (Lorenz
et al., 2000
). Briefly, C. albicans cells were
grown in YPD medium at 30°C to stationary phase for 48 h, washed
twice with water and once with MES buffer (10 mM, pH 6, containing 0.5 mM EDTA, pH 7.4), and then resuspended into MES buffer at
OD600 of 2. After addition of 100 mM glucose,
500-µl aliquots were transferred at different time points to test
tubes each containing 600 µl of acid-washed glass beads and 500 µl
of 10% trichloroacetic acid. The tubes were mixed and immediately
frozen in liquid nitrogen. After 30 min, the cells were thawed,
disrupted by a bead-beater at 4°C, and centrifuged for 10 min at
20,000 × g. The samples were neutralized by washing
the supernatant five times with water-saturated ether, lyophilized, and
then resuspended in 500 µl of assay buffer (0.05 M acetate buffer, pH
5.8, 0.02% [wt/vol] bovine serum albumin). cAMP levels were
determined by with the use of the EIA system-cAMP immunoassay
(Amersham Pharmacia Biotech, Piscataway, NJ) according to the
manufacturer's instructions.
Macrophage Cytopathology Assays
The mouse macrophage cell line RAW264.7 clone D3 (kindly provided by A. Descoteaux, IAF, Laval, Canada) was cultured in an eight-chambered Permanox slide (Lab-Tek, Naperville, IL) at a cell density of 105 cells/well in Dulbecco's modified Eagle's medium (DMEM; Life Technologies-BRL, Rockville, MD) supplemented with 10% heat-inactivated fetal bovine serum (D-10) at 37°C in a 5% CO2 atmosphere for 24 h. Before the addition of C. albicans cells, the chambers were washed once with D-10 medium.
C. albicans cells were grown in YPD medium at 30°C to stationary phase and then washed twice with phosphate-buffered saline, pH 7.4 (PBS). These cells were then added to macrophages at a ratio of 2.5:1. After incubation at 37°C in 5% CO2 atmosphere for 1-4 h, slides were washed three times with D-10 medium, incubated at 4°C for 1 h with 100 µl of rabbit anti-C. albicans antibodies (Accurate Chemical & Scientific Corp., Westbury, NY) diluted 1:200 in D-10 medium. Slides were washed four times with cold D-10 medium, fixed with the use of HEMA3 fixative (Biochemical Sciences Inc.) according to the manufacturer's instructions, washed three times with D-10 medium, and then incubated with FITC-conjugated F(ab)'2 donkey anti-rabbit antibodies (Jackson ImmunoResearch Laboratories Inc., West Grove, PA) diluted 1:100 in D-10. After 45 min of incubation at room temperature, wells were washed four times with PBS, and the slides were mounted in Prolong antifade mounting medium (Molecular Probes, Eugene, OR). Epifluorescence was monitored with the use of a Leitz Laborlux S microscope equipped with a CoolSnap CCD camera (Photometrics, Tucson, AZ) at a magnification of 1000×.
To analyze the survival rate of C. albicans cells exposed to macrophages, we used an end-point dilution survival assay. One milliliter of a saturated C. albicans culture grown in YPD was washed twice in D-PBS, sonicated, and resuspended at 107 cells/ml in cold D-10. Fifty microliters of the suspension was added to 150 µl of D-10 in 96-well plates containing medium only or macrophages. After serial fourfold dilutions, plates were incubated on ice for 30 min and subsequently for 48 h at 37°C in 5% CO2 atmosphere. Colonies were visualized with the use of a Nikon (Garden City, NY) TMS inverted microscope at 20× or 100× magnification.
Virulence Studies
Eight- to 10-week-old female BALB/c mice were obtained from
Charles Rivers Breeding Laboratories (Sulzfeld, Germany). Mucosal infection of the vaginal canal was initiated by inoculating mice (5-8
for each group) intravaginally with 5 × 104
stationary phase cells of the wild-type strain CR340 or 4 × 105 stationary phase cells of the homozygous
cacdc35
mutant strain CR323 taken up in 20 µl of PBS
(Fidel et al., 1993
). To induce pseudoestrus during the
infection, mice were injected subcutaneously with 0.02 mg/mouse
estradiol valerate (Sigma Chemical, St. Louis, MO) in 0.1 ml sesame oil
72 h before inoculation with C. albicans cells (Sobel
et al., 1985
; Ryley and McGregor, 1986
; Fidel et al., 1993
). Estradiol treatments were continued at weekly
intervals thereafter. After killing, the vaginas of the animals were
lavaged with 100 µl of PBS, and the vaginal fungal burden was
quantified by determination of colony-forming units (CFU) as previously
described (Fidel et al., 1993
).
For systemic infections, groups of 10 mice were inoculated with 5 × 105 wild-type cells of strain CR340 or 4 × 106 mutant cells of strain CR323 by
intravenous injection and monitored for survival as described (Csank
et al., 1997
, 1998
; Timpel et al., 1998
). The
eightfold excess of mutant cells was used to compensate for the slower
growth rate of these cells. Survival curves were calculated according
to the Kaplan-Meier method with the use of the PRISM program (GraphPad
Software, San Diego, CA) and analyzed by with the use of the log-rank
test. A p value < 0.05 was considered as significant.
Accession Number
The GenBank/EMBL Data Library accession number for CaCDC35 is AF295379.
| |
RESULTS |
|---|
|
|
|---|
Isolation and Characterization of CaCDC35
The CaCDC35 gene was identified in a screen searching
for C. albicans genes capable of complementing the
conditional growth defect of S. cerevisiae ras1
ras2ts cells. In addition to clones carrying the
CaRAS1 gene (Leberer et al., 2001
), we
isolated two overlapping clones with the potential to encode either the
carboxyl terminal catalytic domain of adenylyl cyclase from amino acid
positions 1253-1690 or a carboxyl terminally truncated version of
adenylyl cyclase from amino acid positions 1-1639, respectively. The
alignment of both sequences generated an open reading frame that
contains no introns and is predicted to encode a protein of 1690 amino
acids with a calculated molecular weight of 186.9 kDa. Our sequence is
identical to that recently determined independently (Mallet et
al., 2000
).
CaCdc35p has overall sequence identities of 32, 26, and 21% with the
homologues of S. cerevisiae (Kataoka et al.,
1985
), M. grisea (Choi and Dean, 1997
), and U. maydis (Gold et al., 1994
), respectively. Like the
other currently known fungal homologues, CaCdc35p has a domain
structure typical of peripheral membrane adenylyl cyclases lacking a
transmembrane domain (Tang and Gilman, 1992
). Typical for this type of
adenylyl cyclases, CaCdc35p has from amino acids 366-983 a central
domain composed of amphipathic leucine-rich repeats of 23 amino acids
(Figure 1A). This region has 42% identity and 58% similarity to
Cdc35p from S. cerevisiae. In S. cerevisiae, this
region has been shown to be required for the interaction of adenylyl
cyclase with the Ras homologues Ras1p and Ras2p (Suzuki et
al., 1990
).
The carboxyl terminal half of CaCdc35p contains the ATP-binding
catalytic domain from amino acid positions 1263-1559 (Figure 1A). This
domain has 26% identity and 48% similarity with the homologous domain
of Cdc35p from S. cerevisiae, but shows less homology to the
catalytic domains of adenylyl cyclases from mammalian cells (Tesmer
et al., 1997
). Like the homologue from S. cerevisiae (Tamura et al., 1989
), CaCdc35p contains a
protein phosphatase 2C
-like domain in the region between the central
and catalytic domains from amino acids 1146-1287 with 31% homology to
human protein phosphatase 2C
(Figure 1A; Mann et al.,
1992
). In comparison to the homologue from S. cerevisiae,
CaCdc35p lacks a stretch of sequence of 381 amino acids at the amino
terminus. The function of this 42-kDa amino terminal region is not
known, although a 100-amino acid region just N-terminal to the central
domain has been shown to be required for optimal regulation of S. cerevisiae adenylyl cyclase by Ras (Colicelli et al.,
1990
).
Chromosomal Deletion of CaCDC35
Both CaCDC35 alleles were deleted in strain CAI4 by homologous recombination in a multistep procedure (Figure 1A). The deletions were confirmed by Southern blot analysis (Figure 1B) and by PCR (our unpublished results). Northern blots showed that the level of the CaCDC35 transcript, which had a size of 6.2 kb, was reduced to ~80% in cells containing a deletion of one allele of CaCDC35 relative to the wild-type strain, and was absent in cells deleted for both alleles (Figure 1C). This transcript was present at about a 40% increased level relative to the wild-type strain when the CaCDC35 gene was reintegrated into the CaTRP1 locus of homozygous mutant cells (Figure 1C, lane 4).
We found that cells deleted for both alleles were viable but grew
~2.5-fold slower than wild-type cells (Table
2). This attenuated growth was observed
in media containing glucose as well as in media containing galactose,
glycerol, or ethanol as carbon sources (our unpublished results). The
growth defect could be complemented by either reintegration of the
wild-type gene into the CaTRP1 locus of homozygous mutant
cells or addition of exogenous cAMP (Table 2), demonstrating that the
defect in growth of mutant cells was caused by disruption of the
function of adenylyl cyclase.
|
As shown in Figure 2, cAMP levels were
undetectable in homozygous mutant cells demonstrating that deletion of
both copies of CaCDC35 resulted in a complete loss of cAMP
production. In agreement with previous work (Niimi, 1984
), we found
that the glucose-induced cAMP burst normally observed in S. cerevisiae cells (Mbonyi et al., 1988
) is not well
developed in C. albicans cells (Figure 2).
|
The ability of C. albicans cells to switch from a yeast-like
to a hyphal mode of growth was not affected by deletion of only one
allele of CaCDC35 (our unpublished results). However,
deletion of both alleles completely blocked the yeast-to-hyphal
transition in all media and under all conditions that we investigated.
When morphological switching was induced in liquid media by either serum or Lee's medium, the homozygous mutant cells were completely defective in the formation of germ tubes or filaments (Figure 3A). On solid agar plates containing
serum or solid Lee's medium (as well as SLAD or Spider media),
the normal formation of hyphae was completely suppressed by deletion of
both alleles of CaCDC35 (Figure 3B). These defects were
reversed by either addition of exogenous cAMP (Figure 3A) or by
reintegration of the wild-type CaCDC35 gene into the
CaTRP1 locus of the homozygous mutant cells (our unpublished
results).
|
The inability of homozygous mutant cells to switch into the hyphal mode
of growth was also corrected by introduction of the CaCDC35
gene on an autonomously replicating plasmid (Figure
4A). However, overexpression of either
the CaRAS1, HST7, or CPH1 genes driven by the
strong ADH1 promoter or moderate overexpression of the EFG1
gene driven by the CaPCK1 promoter failed to suppress the
hyphal switch defect (Figure 4A).
|
In agreement with previous observations (Feng et al.,
1999
; Leberer et al., 2001
), we found that expression
of the hyperactive G13V mutant version of CaRas1p in wild-type cells
both induced the formation of hyphae under conditions that favor the
yeast mode of growth and enhanced the formation of hyphae under
inducing conditions (Figure 4B). These effects of the hyperactive
CaRas1p mutant allele were completely blocked by deletion of both
CaCDC35 alleles (Figure 4B).
Role of CaCdc35p in Phagocytosis of C. albicans Cells by Macrophages
We monitored the uptake of C. albicans cells by
macrophages through an immunofluorescence procedure that distinguished
between C. albicans cells that were either free in the
medium or attached to the external surface of macrophages from those
cells that were undergoing phagocytosis. Cells that were not yet
undergoing phagocytosis were accessible to antibodies and hence could
be immunostained, whereas cells already engulfed by the macrophages
were not stained by this procedure. Candida cells, either in yeast or
hyphal form, could be phagocytosed (Figure
5 and our unpublished results). C. albicans wild-type cells developed long hyphal tubes either inside
or outside of macrophages. This growth allowed them to escape the
macrophage engulfment. In contrast, the homozygous cacdc35
/cacdc35
mutant cells engulfed by macrophages
were completely blocked in the formation of hyphae, and this inability
to form hyphae prevents them from escaping phagocytosis. Their slower growth rate may also contribute to their susceptibility. Quantification of this host-pathogen interaction with the use of an end-point dilution survival assay (see MATERIALS AND METHODS) indicated that
C. albicans adenylyl cyclase defective cells were more
readily killed through interaction with macrophages than were the
wild-type cells (Table 3).
|
|
Requirement of Adenylyl Cyclase for Virulence
To investigate whether CaCdc35p is required for virulence in a
mucosal model of murine candidiasis, we inoculated mice intravaginally with C. albicans cells and monitored for fungal survival on
the vaginal mucosa. In contrast to homozygous mutant cells transformed with a plasmid carrying the wild-type CaCDC35 gene, mutant
cells carrying an empty control plasmid were completely cleared from the vaginal mucosa by day 15, although the initial number of cells applied to the mucosa was eightfold higher for mutant cells than for
wild-type cells to compensate for their slower growth rate (Figure
6).
|
To investigate whether CaCdc35p is required for virulence in systemic
candidiasis, mice were inoculated intravenously with C. albicans cells and monitored for survival. As illustrated in Figure 7, inoculation with homozygous
mutant cells transformed with a plasmid carrying the CaCDC35
gene resulted in complete mortality after 16 d. However, all mice
that were infected with mutant cells transformed with an empty control
plasmid survived for at least 42 d, even when the number of
C. albicans mutant cells injected into the animals was
eightfold higher than the inoculation number of wild-type cells to
compensate for their slower growth rate (Figure 7). All of the animals
infected with mutant cells showed absolutely no clinical signs of
disease.
|
| |
DISCUSSION |
|---|
|
|
|---|
We have cloned and sequenced the C. albicans CaCDC35
gene, which encodes a homologue of fungal adenylyl cyclases. In
contrast to mammalian adenylyl cyclases that are characterized by two
blocks of transmembrane segments, fungal adenylyl cyclases lack
transmembrane domains and appear to be peripherally bound to the cell
membrane (Tang and Gilman, 1992
). CaCdc35p has a domain structure
typical of the currently known fungal adenylyl cyclases (Figure 1A) and has some similarity to the mammalian isoforms around the catalytic core. Other similarity found with mammalian proteins is located in a
region of unknown function that shows 31% homology with protein phosphatase 2C
. In contrast to the mammalian enzymes, the fungal isoforms appear to be regulated by Ras through the interaction of this
small GTP binding protein with a leucine-rich repeat domain in the
central region of adenylyl cyclase (Suzuki et al., 1990
). This Ras binding domain is highly conserved in CaCdc35 suggesting that
the C. albicans protein has the potential to interact with the recently identified C. albicans Ras homologue CaRas1p
(Feng et al., 1999
).
Deletion of both CaCDC35 alleles completely abolished
detectable levels of intracellular cAMP (Figure 2), suggesting that CaCdc35p is the only enzyme capable of producing cAMP in C. albicans cells. The mutant cells were viable, indicating that cAMP
is not essential for vegetative growth in C. albicans cells.
However, mutant cells exhibited significantly reduced growth rates
(Table 2). This mutant phenotype could be complemented by addition of exogenous cAMP (Table 2), suggesting that cAMP-dependent mechanisms contribute to not yet identified steps during vegetative growth of
C. albicans. In this context, C. albicans
resembles M. grisea, U. maydis, S. pombe, and
N. crassa, where adenylyl cyclase genes are not essential
(Terenzi et al., 1976
; Kawamukai et al., 1991
; Gold et al., 1994
; Choi and Dean, 1997
) but differs from
S. cerevisiae, where Cdc35p is essential for progression of
cells through G1 of the cell cycle (Matsumoto et al., 1982
;
Kataoka et al., 1985
). It is tempting to speculate that the
reason for this functional diversity may be an important attribute in
C. albicans for resisting stresses such as nutritional
limitation. Although in S. cerevisiae the cAMP signaling
pathway is primarily involved in mediating nutritional signals to the
cell cycle machinery, in C. albicans the main function of
this pathway could be to mediate stress signals to the morphogenetic
machinery that controls the yeast-to-hyphal transition as part of a
survival strategy. The observation that the highly similar cyclase
proteins of C. albicans and S. cerevisiae provide
an essential function in one organism and not the other suggests that
it is the function of the downstream targets that determine whether
cAMP formation is required for viability.
This interpretation is consistent with our finding that C. albicans cells deleted for both CaCDC35 alleles are
completely deficient in the ability to switch from the yeast mode of
growth into the hyphal mode under all environmental conditions that we investigated (Figure 3). This morphogenetic defect could be cured by
addition of exogenous cAMP (Figure 3A), demonstrating that the
catalytic function of CaCdc35p is responsible for the induction of
hyphal formation in response to environmental cues. Consistent with the
view that Ras is a regulator of fungal adenylyl cyclases (DeFeo-Jones
et al., 1985
; Toda et al., 1985
; Broek et
al., 1987
; Field et al., 1988
), the filament-inducing
activity of the hyperactive G13V mutant version of CaRas1p was
completely blocked in CaCdc35p-deleted mutant cells (Figure 4B). This
epistatic relationship places the function of CaRas1p upstream of
adenylyl cyclase.
We have previously proposed that coordinated activation of both the
filament-inducing MAP kinase cascade and the cAMP signaling pathway
initiates morphogenetic processes in a Ras-dependent manner (Leberer
et al., 2001
). The requirement for dual regulation of morphogenetic switching is corroborated by our studies reported here.
In contrast to the morphogenetic switching defect of homozygous caras1
mutant cells (Feng et al., 1999
), the
switching defect of homozygous cacdc35
mutant cells could
not be complemented by overexpression of Hst7p or Cph1p (a protein
kinase and a transcription factor, respectively, in the filament
inducing MAP kinase cascade; Liu et al., 1994
; Kohler and
Fink, 1996
; Leberer et al., 1996
) or Efg1p (a putative
transcription factor believed to respond to the cAMP signaling pathway;
Stoldt et al., 1997
; Whiteway, 2000
; Figure 4A). A plausible
interpretation for this observation is that stimulation of the
filament-inducing MAP kinase cascade is only capable of inducing hyphal
formation during simultaneous elevation of cAMP levels and that Efg1p
is a direct target of the cAMP pathway requiring cAMP-dependent
activation. By analogy with the dual regulation of the S. cerevisiae adenylyl cyclase by Ras and Gpa2p (Thevelein and de
Winde, 1999
), it is tempting to speculate that in homozygous
caras1
mutant cells this requirement is fulfilled through
stimulation of CaCdc35p by a G protein
subunit homologue similar to
Gpa2p in S. cerevisiae. This explanation is supported by the
findings that overexpression of either components of the
filament-inducing MAP kinase cascade or of Efg1p can complement the
yeast-to-hyphal switching defect of homozygous caras1
mutant cells (Leberer et al., 2001
). In addition,
overexpression of Efg1p complements the switching defect of mutant
cells deleted for a homologue of protein kinase A (Sonneborn et
al., 2000
).
Our finding that adenylyl cyclase mutants defective in the formation of
hyphae are more vulnerable to phagocytosis by macrophages (Table 3)
supports the hypothesis that the yeast-to-hyphal transition is part of
a survival strategy of C. albicans to escape the cellular immune system (Lo et al., 1997
). This view is supported by
our in vivo studies in mouse models for mucosal and systemic
infections. In contrast to wild-type cells, mutant cells were rapidly
eradicated from the mucosa after vaginal infection (Figure 6). Mice
intravenously infected with mutant cells survived without any clinical
signs of disease, whereas mice infected with wild-type cells were
efficiently killed (Figure 7). It is unclear whether the defects in
virulence are caused by reduced growth of the mutant cells or by
defects in morphogenetic switching. However, because we have used eight times more mutant cells than wild-type cells for infection of the
animals, it is more likely that the defects in virulence were caused by
defects in morphological transitions than by the reduced growth.
In summary, we propose that CaCdc35p represents a key regulatory element in the cAMP signaling pathway and is part of a sensory system involved in detecting changes in the environment and sending signals to a morphogenetic machinery that controls the mode of growth. These interconnected signaling and morphogenetic systems are part of a strategy of C. albicans to resist environmental stresses and thereby contribute to the virulence of this human pathogen. Because CaCdc35p and other fungal adenylyl cyclases differ significantly in their type of regulation from their mammalian counterparts, the fungal adenylyl cyclases and their regulators could represent very attractive targets for the identification of specific inhibitors with antifungal activity.
| |
ACKNOWLEDGMENTS |
|---|
The authors thank Tamara Michaeli for providing the S. cerevisiae strain TTM3-4B; C. Boone for providing the C. albicans genomic library; W.A. Fonzi, B. Magee, J.F. Ernst, and A. Brown for providing plasmids and C. albicans strains; and A. Descoteaux for providing the mouse macrophage cell lines. The authors are grateful to M. Pelletier for help with data processing in the cAMP assays and to Ursula Oberholzer for her comments on the manuscript. C.R.C.R. was supported by a postdoctoral fellowship from Fundação de Amparo à pesquisa do Estado de São Paulo (FAPESP), Brazil. This is National Research Council of Canada publication number 44794.
| |
FOOTNOTES |
|---|
¶ Corresponding author: Aventis Pharma, Center for Functional Genomics, Fraunhoferstrasse 13, D-82152 Martinsried, Germany. E-mail address: Ekkehard.Leberer{at}aventis.com.
| |
REFERENCES |
|---|
|
|
|---|